Reporting Live From the Virtual Opium Den of Tomorrow
Local journalism is being pulled in two directions. Congress is trying to help “journalism” while Big Tech is trying to blow up “local.”
Local journalism is being pulled in two directions. Congress is trying to help “journalism” while Big Tech is trying to blow up “local.”
WhoWhatWhy has found evidence linking the Saudi royal family to Saudis in South Florida who reportedly had direct contact with the 9/11 hijackers before fleeing the United States just prior to the attacks.
The FEC, America’s top election watchdog, is failing. The person who ran it in 2015 spoke with WhoWhatWhy about how hopeless the situation has become.
Environmental activists scored a huge victory after a Virginia judge overturned a permit for the massive pipeline. Now big energy companies are lobbying Congress to overturn the ruling.
In relative obscurity, Congress is about to hand President Donald Trump permanent surveillance powers over US citizens. Most Americans don’t even seem to know how this controversial legislation would affect them. Here is what’s at stake.
With government monitoring lagging behind, members are installing their own monitors.
Two young activists transform Florida politics, engaging voters all year. Discover their journey and the power of grassroots politics.
If we can overcome its pitfalls, AI holds promise for improving trust in climate science and activating a largely disengaged public, with meaningful consequences for health and well-being globally.
The current reality may be far more dangerous than past nuclear threats: Richard Clarke, the first White House official placed in charge of US cybersecurity policy, looks at the dangers of cyber warfare today.
Russ Baker and veteran podcaster Peter B. Collins discuss the downfall and disgrace of New York politician Anthony Weiner, the effect it had on the 2016 presidential election, and what unseen forces may have been working behind the scenes.
Harvard law professor Martha Minow on the state of the news business today, and why she thinks the government should play more of a role.
Voters in one key state will decide this November on a ballot initiative aiming to control the wild spikes in drug prices. Will consumer outrage at the ever-rising cost of medication translate into support for similar actions across the country? Or will Big Pharma and the politicians it funds nip this burgeoning movement in the bud?